A9699 HCPCS code: Radiopharmaceutical, therapeutic, not otherwise classified
A9699 is the HCPCS Level II code for radiopharmaceutical, therapeutic, not otherwise classified. In 2022 Medicare paid an average of $9,609.70 per service for A9699 across 1,278 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. In 2022, about 61 clinicians billed Medicare for A9699 for 214 beneficiaries; Georgia, Texas, Nebraska accounted for 81% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 57 |
| BETOS category | I1E |
| Added | 2003-01-01 |
| Last action effective | 2006-01-01 |
Who bills A9699 (2022)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 61 |
| Medicare beneficiaries | 214 |
| States with claims | 9 |
| Share of services in top 3 states (Georgia, Texas, Nebraska) | 81% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9699, 2022–2022
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,278 | 214 | $12,058.34 | $9,609.70 |
States with the most A9699 services (2022)
| State | Services | Avg. paid |
|---|---|---|
| Georgia | 578 | $2,658.24 |
| Texas | 44 | $37,977.86 |
| Nebraska | 37 | $33,356.76 |
| Virginia | 32 | $35,760.26 |
| Arkansas | 27 | $36,760.72 |
Medicare policy articles for this code
- A54880: Billing and Coding: Additional Claim Documentation Requirements for Not Otherwise Classified (NOC) Drugs and Biological Products with Specific FDA Label Indications (Palmetto GBA (MAC - Part A, MAC - Part B))
What changed for A9699
- 2003-01-01: A9699 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9699?
A9699 is the HCPCS Level II code for radiopharmaceutical, therapeutic, not otherwise classified. Short descriptor: "Radiopharm rx agent noc".
How much does Medicare pay for A9699?
In 2022, the average Medicare payment was $9,609.70 per service (average allowed $12,058.34).
Does Medicare cover A9699?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related A96 codes
- A9600 — Strontium sr-89 chloride, therapeutic, per millicurie
- A9601 — Flortaucipir f 18 injection, diagnostic, 1 millicurie
- A9602 — Fluorodopa f-18, diagnostic, per millicurie
- A9603 — Injection, pafolacianine, 0.1 mg
- A9604 — Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
- A9606 — Radium ra-223 dichloride, therapeutic, per microcurie
- A9607 — Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie
- A9608 — Flotufolastat f 18, diagnostic, 1 millicurie
- A9609 — Fludeoxyglucose f18 up to 15 millicuries
- A9610 — Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- A9611 — Flurpiridaz f 18, diagnostic, 1 millicurie
- A9612 — Injection, fluorescein, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9699
- Watch A9699 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9699
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.